KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Debt to Equity (2016 - 2025)

Quest Diagnostics' Debt to Equity history spans 17 years, with the latest figure at $0.79 for Q4 2025.

  • For Q4 2025, Debt to Equity fell 13.76% year-over-year to $0.79; the TTM value through Dec 2025 reached $0.79, down 13.76%, while the annual FY2025 figure was $0.79, 13.76% down from the prior year.
  • Debt to Equity for Q4 2025 was $0.79 at Quest Diagnostics, up from $0.78 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.91 in Q3 2024 and bottomed at $0.59 in Q1 2021.
  • The 5-year median for Debt to Equity is $0.67 (2022), against an average of $0.71.
  • The largest annual shift saw Debt to Equity dropped 16.51% in 2021 before it skyrocketed 38.96% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.62 in 2021, then grew by 8.45% to $0.67 in 2022, then increased by 10.72% to $0.74 in 2023, then grew by 22.79% to $0.91 in 2024, then dropped by 13.76% to $0.79 in 2025.
  • Per Business Quant, the three most recent readings for DGX's Debt to Equity are $0.79 (Q4 2025), $0.78 (Q3 2025), and $0.78 (Q2 2025).